TY - CHAP M1 - Book, Section TI - Chapter 8. Metabolic Bone Disease A1 - Shoback, Dolores A1 - Sellmeyer, Deborah A1 - Bikle, Daniel D. A2 - Gardner, David G. A2 - Shoback, Dolores Y1 - 2011 N1 - T2 - Greenspan’s Basic & Clinical Endocrinology, 9e AB - ACTH AdrenocorticotropinADHR Autosomal dominant hypophosphatemic ricketsAHO Albright hereditary osteodystrophyAIRE Autoimmune regulatorBMD Bone mineral densityCaSR Extracellular calcium-sensing receptorCGRP Calcitonin gene–related peptideDBP Vitamin D–binding proteinDXA Dual-energy x-ray absorptiometryFBHH Familial benign hypocalciuric hypercalcemiaFGF23 Fibroblast-derived growth factor 23GALNT3 UDP-N-acetyl-α-D-galactosamine transferaseHPT-JT Hyperparathyroidism-jaw tumorHT Hormone therapyICMA Immunochemiluminescent assayIFN InterferonIGF Insulin-like growth factorIL InterleukinIP3 Inositol 1,4,5-triphosphateIRMA Immunoradiometric assayLDL Low-density lipoproteinMCT Medullary carcinoma of thyroidMEN Multiple endocrine neoplasiaMEPE Matrix extracellular phosphoglycoproteinNALP5 NACHT leucine-rich-repeat protein 5OPG OsteoprotegerinPHP PseudohypoparathyroidismPIP2 Phosphatidylinositol 4,5-bisphosphatePPHP Pseudo pseudohypoparathyroidismPTH Parathyroid hormonePTHrP Parathyroid hormone–related proteinRANK Receptor activator of nuclear factor kappa BRANKL Receptor activator of nuclear factor kappa-B ligandRAR Retinoic acid receptorRBP Retinol-binding proteinRXR Retinoid X receptorSERMs Selective estrogen response modulatorssFRP Secreted frizzled related proteinTNF Tumor necrosis factorTPN Total parenteral nutritionTRP Tubular reabsorption of phosphateVDR Vitamin D receptorVDRE Vitamin D response elementVIP Vasoactive intestinal polypeptideWHI Women's Health InitiativeWHO World Health OrganizationXLH X-linked hypophosphatemia SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/04/19 UR - accessbiomedicalscience.mhmedical.com/content.aspx?aid=8402654 ER -